Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
American Heart Journal|March 20, 1998
Absence of a deleterious effect of calcium channel blockers in patients with left ventricular dysfunction after myocardial infarction: The SAVE Study Experience. SAVE Investigators. Survival and Ventricular EnlargementW D Hager, B R Davis, A Riba, et al.
Circulation|August 5, 1997
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement InvestigatorsG A Lamas, G F Mitchell, G C Flaker, et al.
Mucosal Immunology|July 13, 2012
Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injuryO Eickmeier, H Seki, O Haworth, et al.
The American Journal of Cardiology|August 15, 1997
Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarctionS C Greaves, G Zhi, R T Lee, et al.
The American Journal of Cardiology|September 28, 1995
Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE InvestigatorsM A Pfeffer, F M Sacks, L A Moyé, et al.
American Heart Journal|February 15, 2001
Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysisY Aikawa, L Rohde, J Plehn, et al.
Kardiologiia|January 1, 1993
[Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies]M A Pfeffer, Iu Braunvald, L A Moĭe, et al.
Lancet (London, England)|September 1, 2000
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trialJ L Rouleau, M A Pfeffer, D J Stewart, et al.
Circulation Research|May 1, 1984
Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the ratK F Badr, C Baylis, J M Pfeffer, et al.
Journal of the American College of Cardiology|July 10, 1999
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE InvestigatorsG C Flaker, J W Warnica, F M Sacks, et al.
Pageof 15